Senescence-associated reprogramming promotes cancer stemness

By M. Milanovic, D. N. Fan, D. Belenki, J. Däbritz, Zhen Zhao, Yong Yu, J. Dörr, L. Dimitrova, D. Lenze, I. Barbosa and 13 more. Nature, 2017

957 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/2aa1b200b77152efe30b387ddeb2ce45b68bd9aa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Raghu Kalluri
2. D. Hanahan

In Molecular Biology

1. Raghu Kalluri
2. M. Nieto
3. R. Weinberg
4. D. Hanahan
5. Zena Werb
6. Youhua Liu

Citations in the corpus

• Drug resistance and combating drug resistance in cancer (2019, background): “Cancer cells with TIS can gain stemcell properties, which accounts for the escape from senescence and cancer relapse[88,89].”
• Systems Biology of Cancer Metastasis (2019, background): “SC-Seq: Comparative transcriptomics to reveal senescent, stem-like, or dormant cells(Marlow and Dontu, 2015; Milanovic et al., 2018) iii.”
• Hallmarks of Cellular Senescence. (2018, neutral): “Finally, it was recently reported that senescent cells express many markers of ‘ stemness ’ [158].”